Sustained Clinical Remission With Vedolizumab in Patients With Moderate-to-Severe Ulcerative Colitis

BACKGROUND: Sustaining clinical remission is an important treatment goal in moderate-to-severe UC. This post hoc exploratory analysis assessed the long-term efficacy of vedolizumab in the subset of patients with UC in the GEMINI 1 study who were in clinical remission by week 14 after 3 induction dos...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Inflamm Bowel Dis
Main Authors: Feagan, Brian G, Schreiber, Stefan, Wolf, Douglas C, Axler, Jeffrey L, Kaviya, Arpeat, James, Alexandra, Curtis, Rebecca I, Geransar, Parnia, Stallmach, Andreas, Ehehalt, Robert, Bokemeyer, Bernd, Khalid, Javaria Mona, O’Byrne, Sharon
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2019
Assuntos:
Original Clinical Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6499937/
https://ncbi.nlm.nih.gov/pubmed/30365009
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ibd/izy323
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares